9004-10-8 | Insulin

Chemical type

• Peptide hormone
• Produced by beta cells in the pancreas

Key properties

• Regulates blood glucose levels by facilitating cellular uptake of glucose
• Insufficient production or inadequate regulation leads to hyperglycemia in DMT2
• Influences long-term complications of diabetes if not properly managed

• Secreted by pancreatic β-cells
• Lowers blood glucose
• Suppressed by elevated catecholamines
• Involved in transient hyperinsulinism in preterm infants

• Therapeutic agent in DMT2 management (e.g., via injections or pumps for patients with poor natural regulation)
• Key factor in self-care and medical treatment for maintaining glucose control
• Referenced in diabetes etiology, but not directly measured in the study's CGM data

• Glucose regulation
• Treatment of hyperglycemia (exogenous insulin therapy)
• Diagnostic evaluation of hypoglycemia

Classification by use

• Hormones in metabolic regulation
• Therapeutic agents for endocrine disorders

• Chemicals used as metabolic hormones
• Chemicals used in diabetes treatment

A trustworthy factory and manufacturer

1. [Cite:1] Use of the Geometric Pattern Transformation to detect diabetes mellitus type 2 from blood Insulin signals, Biomedical Engineering Advances, Volume 11, June 2026, 100205
2. [Cite:2] Association of Catecholamines with Blood Glucose and Severity of Illness in Infants Born Preterm, The Journal of Pediatrics, Volume 289, February 2026, 114897